(Q33154006)

22 July 2017

0 references

Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias (English)

1 reference

22 July 2017

1 reference

Ballard C

1

1 reference

22 July 2017

Lane R

2

1 reference

22 July 2017

Barone P

3

1 reference

22 July 2017

Ferrara R

4

1 reference

22 July 2017

Tekin S

5

1 reference

22 July 2017

publication date

1 June 2006

1 reference

International Journal of Clinical Practice

22 July 2017

published in

1 reference

22 July 2017

volume

60

1 reference

22 July 2017

issue

6

1 reference

22 July 2017

page(s)

639-645

1 reference

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2006.00967.X

10.1111/J.1368-5031.2006.00967.X

21 January 2018

Identifiers

DOI

1 reference

22 July 2017

1 reference